JB
Distinguished in Metastatic Brain Tumor
Check Dr. Jeffrey N. Bruce's experience treating your condition:
About Dr. Jeffrey N. Bruce

Jeffrey Bruce is a Neurosurgery expert in New York, New York. Bruce has been practicing medicine for over 40 years and is rated as a Distinguished expert by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 33 other conditions, according to our data. His top areas of expertise are Brain Tumor, Glioblastoma, Astrocytoma, Gamma Knife Radiosurgery, and Awake Craniotomy. He is licensed to treat patients in New Jersey and New York.

His clinical research consists of co-authoring 226 peer reviewed articles and participating in 5 clinical trials in the past 15 years. In particular, he has co-authored 7 articles in the study of Metastatic Brain Tumor.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Jeffrey N. Bruce it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Locations
710 W 168th St, New York, NY 10032
Background & Education
Graduate Institution
Other, 1983
Specialties
Neurosurgery
Licenses
Neurological Surgery in NY
Hospital Affiliations
NewYork-Presbyterian/Weill Cornell Medical Center
Boca Raton Regional Hospital
NewYork-Presbyterian/Columbia University Irving Medical Center
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


5 Clinical Trials

Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
Chronic Convection Enhanced Delivery of Topotecan for Recurrent High Grade Gliomas
A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration Positive Patients With Stage IV Squamous Cell Lung Cancer (Lung-Map Sub-Study)
A Phase I Study of Topotecan by Intracerebral Clysis for the Treatment of Recurrent Primary Malignant Brain Tumors
View 4 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Elite
Elite
Elite